Zuci Zheng

Title: Zuci Zheng: Innovator in Urine-Modified Nucleoside Detection

Introduction

Zuci Zheng is a notable inventor based in Fujian, China. He has made significant contributions to the field of medical diagnostics, particularly in the detection of urine-modified nucleosides. His innovative approach utilizes advanced spectroscopy techniques to enhance diagnostic accuracy.

Latest Patents

Zuci Zheng holds a patent for a "Detection and analysis method for urine-modified nucleoside based on surface-enhanced resonance Raman spectroscopy." This invention presents a method for extracting tumor marker modified nucleosides from urine samples of both normal individuals and cancer patients. The technique employs borophenylic acid gel for specificity and utilizes Au colloid as an enhancing substrate to detect SERRS signals. The statistical analysis is performed using PLS-DA algorithms, establishing a diagnostic model that can effectively differentiate between normal and cancerous urine-modified nucleosides. The model boasts a specificity of 96.9%, sensitivity of 98.2%, and accuracy of 97.6%. This rapid and objective detection method provides crucial insights for medical professionals in diagnosing esophagus cancer.

Career Highlights

Zuci Zheng is affiliated with Fujian Normal University, where he continues to advance research in medical diagnostics. His work has garnered attention for its innovative application of spectroscopy in clinical settings. Zheng's contributions are paving the way for more effective cancer detection methods.

Collaborations

Zuci Zheng has collaborated with colleagues such as Shangyuan Feng and Qiwen Wang. Their joint efforts in research have further enhanced the development of diagnostic technologies.

Conclusion

Zuci Zheng's innovative work in the detection of urine-modified nucleosides represents a significant advancement in medical diagnostics. His patented method not only improves diagnostic accuracy but also offers a rapid and objective approach to cancer detection.